|
Volumn 16, Issue 1, 2001, Pages 37-43
|
Combination of antidepressant drugs: The case of inositol
|
Author keywords
Antidepressant; Combination; Inositol
|
Indexed keywords
ANTIDEPRESSANT AGENT;
CLOMIPRAMINE;
DESIPRAMINE;
DOPAMINE;
DOPAMINE RECEPTOR;
DOPAMINE RECEPTOR BLOCKING AGENT;
FENCLONINE;
FLUOXETINE;
FLUVOXAMINE;
INOSITOL;
LITHIUM;
MONOAMINE OXIDASE INHIBITOR;
PAROXETINE;
PHOSPHATIDYLINOSITOL;
PINDOLOL;
PLACEBO;
RECEPTOR SUBTYPE;
RITANSERIN;
SEROTONIN;
SEROTONIN 2 ANTAGONIST;
SEROTONIN 2 RECEPTOR;
SEROTONIN RECEPTOR;
SEROTONIN UPTAKE INHIBITOR;
THYROXINE;
TRICYCLIC ANTIDEPRESSANT AGENT;
ADULT;
AGED;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CLINICAL TRIAL;
COMPULSIVE PERSONALITY DISORDER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG POTENTIATION;
FEMALE;
HUMAN;
LATENT PERIOD;
MALE;
NONHUMAN;
PRECURSOR;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SECOND MESSENGER;
SIDE EFFECT;
|
EID: 0035104108
PISSN: 08856222
EISSN: None
Source Type: Journal
DOI: 10.1002/hup.181 Document Type: Article |
Times cited : (9)
|
References (31)
|